Phosphorylation of spleen tyrosine kinase at tyrosine 348 (pSyk³⁴⁸) may be a marker of advanced phase of Chronic Myeloid Leukemia (CML). [electronic resource]
Producer: 20150507Description: 329-34 p. digitalISSN:- 1873-5835
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols
- Biomarkers, Tumor
- Blast Crisis
- Child
- Chronic Disease
- Dasatinib
- Disease Progression
- Female
- Flow Cytometry
- Follow-Up Studies
- Humans
- Intracellular Signaling Peptides and Proteins -- genetics
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- drug therapy
- Male
- Middle Aged
- Oxazines -- pharmacology
- Phosphorylation
- Prognosis
- Protein Kinase Inhibitors -- pharmacology
- Protein-Tyrosine Kinases -- genetics
- Pyridines -- pharmacology
- Pyrimidines -- pharmacology
- RNA, Messenger -- genetics
- Real-Time Polymerase Chain Reaction
- Reverse Transcriptase Polymerase Chain Reaction
- Survival Rate
- Syk Kinase
- Thiazoles -- pharmacology
- Tumor Cells, Cultured
- Young Adult
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.